ACTRN12610000090011
Not yet recruiting
未知
utrigenomic risk profiles for Mild Cognitive Impairment, Alzheimer's disease and Parkinson's disease
Commonwealth Scientific and Industrial Research Organisation0 sites900 target enrollmentJanuary 27, 2010
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- eurodegenerative diseases
- Sponsor
- Commonwealth Scientific and Industrial Research Organisation
- Enrollment
- 900
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Control Group:
- •Male or female, Aged 55 and above, Not clinically diagnosed with mild cognitive impairment, Alzheimer's disease and Parkinson's, No family history of mild cognitive impairment, Alzheimer's disease and Parkinson's disease
- •Mild cognitive impairment Group:
- •Male or female, Aged 55 and above, Clinically diagnosed with mild cognitive impairment
- •Alzheimer's disease Group:
- •Male or female, Aged 55 and above, Clinically diagnosed with Alzheimer's disease
- •Parkinson's disease Group:
- •Male or female, Aged 55 or above, Clinically diagnosed with Parkinson's disease
Exclusion Criteria
- •Control Group:
- •Patients who are undergoing chemotherapy,radiotherapy treatment for cancer, patients that are supplementing with above recommended dietary intakes of micronutrients associated with genome maintenance
- •Mild cognitive impairment Group:
- •Patients who are undergoing chemotherapy, radiotherapy treatment for cancer, patients that are supplementing with above recommended dietary intakes of micronutrients associated with genome maintenance
- •Alzheimer's disease Group:
- •Patients who are undergoing chemotherapy, radiotherapy treatment for cancer, patients that are supplementing with above recommended dietary intakes of micronutrients associated with genome maintenance
- •Parkinson's disease Group:
- •Patients who are undergoing chemotherapy, radiotherapy treatment for cancer, patients that are supplementing with above recommended dietary intakes of micronutrients associated with genome maintenance
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Risk Model of Cognitive Impairment in DiabetesType 2 Diabetes MellitusMild Cognitive ImpairmentNCT05590442The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School500
Terminated
Not Applicable
Development of Risk Models for Cognitive Decline and Delirium in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI)Aortic stenosisDeliriumCognitive declineCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemMental Health - Other mental health disordersSurgery - Other surgeryACTRN12618001114235niversity of South Australia32
Recruiting
Not Applicable
Intervention and Biomarker for Mild Cognitive ImpairmentMild Cognitive ImpairmentJPRN-UMIN000034676Shimane University35
Not yet recruiting
Phase 3
The survey to find out the number of individuals having difficulty in remembering or learning new things and its effect on mobility and balance in elderly population in Hubli DharwadCTRI/2019/09/021124Chougule Snehal Sanjay
Recruiting
Not Applicable
prospective study of mild cognitive impairment and dementia in Kurashiki.JPRN-UMIN000035971Kawasaki Medical School1,000